癌抑制遺伝子産物の生理機能

• Project/Area Number: 07272110
• Research Category: Grant-in-Aid for Scientific Research on Priority Areas
• Allocation Type: Single-year Grants
• Research Institution: National Cancer Center Research Institute and Research Center for Innovative Oncology, National Cancer Center Hospital East
• Principal Investigator: 田矢 洋一 国立がんセンター, 研究所生物学部, 室長 (60133641)
• Co-Investigator(Kenkyū-buntansha): 神田 忠仁 国立予防衛生研究所, 室長 (60134615) ; 松七五三 仁 東京大学, 医科学研究所, 助教授 (50251442) ; 野田 哲生 癌研究所, 部長 (10183550) ; 土田 信夫 東京医科歯科大学, 歯学部, 教授 (60089951) ; 小田 鈎一郎 東京理科大学, 基礎工学部, 教授 (40012736)
• Project Period (FY): 1995
• Project Status: Completed (Fiscal Year 1995)
• Budget Amount: ¥17,300,000 (Direct Cost: ¥17,300,000); Fiscal Year 1995: ¥17,300,000 (Direct Cost: ¥17,300,000)
• Keywords: RB蛋白質 / p53 / 癌抑制遺伝子 / サイクリンD / Cdk4 / Cdkインヒビター / mgl-1 / ヒトパピローマウィルス

Research Abstract

1.酵母のTwo-hybrid系を利用して、HPV16のE6蛋白と複合体を形成する2つの細胞蛋白を得た。1つは、HUMHMCM2(酵母MCM2のヒトホモログ)であり、他の1つは未知の蛋白(約60Kd)であった。
2.サイクリンD1-Cdk4が、他のサイクリンEやA依存性キナーゼとは異なったアミノ酸配列の所をリン酸化することを初めて明らかにした。サイクリンD1は癌遺伝子にもなるサイクリンであるので、この発見によって、サイクリンD1が細胞癌化に関与するメカニズムの解明が大きく進展すると期待できる。
3.Drosophilaの癌抑制遺伝子l(2)glのマウスホモログmgl-1ならびにmgl-2遺伝子の機能をジーンターゲッティングにより解析した。mgl-1ホモ欠損マウスでは水頭症を呈し、出生後48時間以内に死亡し、組織学的には神経上皮細胞の異常が認められた。一方、mgl-2ホモ欠損マウスは、ほとんどが生殖能力を有する生体となるが、すべて矮小であった。
4.p21の変異蛋白を複数作製して精製し、アミノ酸置換されたp21はサイクリンDl/Cdk4複合体に結合するがその酵素活性を阻害できないことを見い出した。この変異p21をp16とともにヒト細胞に発現させると、p16に拮抗的な変異p21の作用が観察された。
5.ラットcdc2プロモーターのGl/S境界での活性化に関与するエンハンサーAAGTTACAAATAに結合する蛋白因子cdc2E1とcdc2E2のcDNAを単離した結果、E1はSRE中のCArGbox結合因子をコードし、E2は未知の遺伝子であることがわかった。

Research Products

• [Publications] Kitagawa, M. et al.: "Phosphorylation of E2F-1 by cyclin A-cdk2." Oncogene. 10. 229-236 (1995)
• [Publications] Ueno, Y. et al.: "Chemical synthesis of phosphopeptides using arylthio group for protection of phosphate : Application to identification of cdc2 kinase-phosphorylation sites." Int. J. Peptide Prot. Res.46. 106-112 (1995)
• [Publications] Hiwasa, T. et al.: "Inhibition of cysteine proteinases and proteosome by Ras, Ran and cyclin." Proteases Involved in Cancer. 183-187 (1995)
• [Publications] Suzuki-Takashi, I. et al.: "The interaction of E2F with pRB and p107 are regulated via the phosphorylation of pRB and p107 by cyclin-dependent kinase." Oncogene. 10. 1691-1698 (1995)
• [Publications] Ueno, Y., et al.: "Solid-phase synthesis of peptides containing O-phosphoryl serine and O-phosphoryl threonine using allyl group for phosphate protection." Bioorg. Med. Chem. Let.5. 823-826 (1995)
• [Publications] Saijo, M. et al.: "Molecular cloning of a human protein that binds to the retinoblastoma protein and chromosomal mapping." Genomics. 27. 551-519 (1995)
• [Publications] Taya, Y.: "Cell cycle-dependent phosphorylation of the tumor suppressor RB protein." Molecules and Cells. 5. 191-195 (1995)
• [Publications] Inoue, A. et al.: "70-kDa heat shock cognate protein directly interacts with N-terminal region of the retinoblastoma gene product pRb-identification of a novel region of pRb mediating protein interaction." J. Biol. Chem.270. 22571-22576 (1995)
• [Publications] Sakai, Y. et al.: "cDNA sequence, chromosomal localization of a novel human protein RBQ-1 which binds to the retinoblastoma gene product." Genomics. 30. 98-101 (1995)
• [Publications] Higashi, H. et al.: "Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro." Biochem. Biophys. Res. Commun.216. 520-525 (1995)
• [Publications] Higashi, H. et al.: "Cdk2 forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin H." Eur. J. Biochem.(in press). (1996)
• [Publications] Kitagawa, M. et al: "The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that of phosphorylation by cyclin A/E-Cdk2." EMBO J.(in press).
• [Publications] Suziki, M. et al.: "An E1A-inducible Sp 1 negative regulator, G10BP represses transcription of the rat fibronectin gene." Mol. Cell. Biol.15. 5423-5433 (1995)
• [Publications] Shimizu, M. et al.: "The G1/S boundary-specific enhancer of the rat cdc2 promoter." Mol. Cell. Biol.15. 2882-2892 (1995)
• [Publications] Nakajima, T. et al.: "Adenovirus E1A-induced apoptosis elicits a steep decrease in the topoisomerase II a level during the latent phase." Oncogene. 10. 651-662 (1995)
• [Publications] Nakamra, T. et al.: "Down-regulation of the cyclin A-promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site." Exp. Cell. Res.216. 422-430 (1995)
• [Publications] Kamada, S. et al.: "bcl-2 Deficiency in mice leads to pleiotropic abnormalities : A ccelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine." Cancer Res.55. 354-359 (1995)
• [Publications] Matsuhisa, A. et al.: "Inositol monophoshatase activity from the Escherichia coli suhB gene product." J. Bacteriol.177. 200-205 (1995)
• [Publications] Uehara, Y. et al.: "Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor." Nature. 373. 702-705 (1995)
• [Publications] Takekura, H. et al.: "Abnormal junctions between surface membrane and sarcoplasmic reticulum in skeltal muscle with a mutation targeted to the ryanodine receptor." Proc. Natl. Acad. Sci. USA. 92. 3381-3385 (1995)
• [Publications] Takeshima, H. et al.: "Ca2+-induced Ca2+release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor." EMBO J.14. 2999-3006 (1995)
• [Publications] Miyashiro, I. et al.: "Subcellular localization of the APC protein : Immunoelectron microscopic study of the association of the APC protein with catenin." Oncogene. 11. 89-96 (1995)
• [Publications] Sakaguchi, S. et al: "Accumulation of proteinase K-resistant PrP is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of Creutzfeldt-Jakob disease agent." J. Virol.69. 7586-7592 (1995)
• [Publications] Shiba, K. et al.: "Human alanyl-tRNA synthetase : conservation in evolution of catalytic core and microhelix recognition." Biochemistry. 34. 10340-10349 (1995)
• [Publications] Takei, Y. et al.: "Synapsin I deficiency results in the structural change in the presynaptic terminal in the murine nervous system." J. Cell. Biol.131. 1789-1800 (1995)
• [Publications] Nakai, S. et al.: "The POU-domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse." Genes Dev.9. 3109-3121 (1995)
• [Publications] Muto, Y. et al.: "Growth retardation in human cervical dysplasia-derived cell lines by β-carotene through doun-regulation of epidermal growth factor receptor." Am. J. Clin. Nutr.(in press).
• [Publications] Matsumoto, M. et al.: "Ataxia and epileptic eizure in mice lacking type 1 inositol 1,4,5-trisphophate receptor." Nature. 379. 168-171 (1996)
• [Publications] Miyatake, S. et al.: "Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas." J. Exp. Med.182. 401-408 (1995)
• [Publications] Suzuki, T. et al.: "HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p161NK4A and counteracts its inhibitory activity to CDK4." EMBO J.(in press).
• [Publications] Munirajan, A. K. et al.: "P53 gene mutations in oralb carcinomas from India." Int. J. Cancer. (in press).
• [Publications] Takada, S. et al.: "Disruption of the function of tumor-suppressor gene p53 by the hepatitis B virus" Res. Clin. Oncol.(in press).
• [Publications] Yamato, K. et al.: "A human temprature-sensitive p53 mutant, p53val-138 ; Modulation of the cell cycle, viability and expression of p53-responsive genes." Oncogene. 11. 1-6 (1995)
• [Publications] Hirano, Y. et al.: "A tempertature sensitive mutant of the human p53, vall38, arrest rat cell growth without induced expression of cip1/waf1/sdi1 after temperature shift-down." Oncogene. 10. 1879-1885 (1995)
• [Publications] Tsutsumi-Ishii, Y.: "Response of heat shock element (HSE) within the human HSP70 promoter to mutated p53 genes." Cell Growth & Differ.6. 1-8 (1995)
• [Publications] Hirano, Y. et al.: "Roles of p53 mutation in cell line establihsment and identification of the munimum transactivation and transform suppression domains." Eur. J. Cancer. 32B. 129-135 (1995)
• [Publications] Sekiguchi, T. et al.: "Apoptosis is induced in BHK cells by the tsBN462/13 mutation in the CCG1/TAFII250 subunit of the TFIID basal transcription factor." Exp. Cell Res.218. 161-164 (1995)
• [Publications] Sugito, K. et al.: "Interaction between hsp70 and hsp40, eucaryotic homologues of DnaK and DnaJ, in human cells expressing mutant-type p53." FEBS Lett.358. 161-164 (1995)
• [Publications] Kanda, T. et al.: "Occurrence of the antibody against humanpapillomavirus type 16 (HPV16) virion protein L2 in patients with cervical cancer and dysplasia." Intervirology. 38. 187-191 (1995)
• [Publications] Nakagawa, S. et al.: "Mutational analysis of human papillomavirus type 16 E6 protein : Transforming function for human cells and degradation of p53 in vitro." Virology. 212. 535-542 (1995)
• [Publications] Sermusvitayawong, K. et al.: "Heterogeneity of Cellular Proteins that bind to the central conserved region of p53." Medical J. of Osaka Univ.47. 341-350 (1995)
• [Publications] Shindo, M. et al.: "Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relationship to p53 and PCNA expression." Cancer. 76. 1513-1521 (1995)
• [Publications] Kitamura, Y. et al.: "Human endogenous retrovirus K10 encodes a functional integrase." J. Virol.(in press).
• [Publications] Dobashi, Y. et al.: "Constitutive overexpression of cdk2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells." J. Biol. Chem.270. 23031-23037 (1995)
• [Publications] Harada, H. et al.: "Activation of a cell cycle regulated histone gene by the oncogenic transcription factor IRF-2." Nature. 377. 362-365 (1995)
• [Publications] Kimura, T. et al.: "Essential and non-redundunt roles of p48 (ISGF3g) and IRF-1 in both type I and type II interferon responses, as revealed by gene targetting studies." Genes to Cells. (in press). (1996)